Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers
- 12 October 2010
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 67 (3) , 277-281
- https://doi.org/10.1007/s00228-010-0907-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/RitonavirClinical Pharmacology & Therapeutics, 2010
- A liquid chromatography–tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIVJournal of Chromatography B, 2009
- Prodrugs of nucleoside analogues for improved oral absorption and tissue targetingJournal of Pharmaceutical Sciences, 2008
- Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with RitonavirAntimicrobial Agents and Chemotherapy, 2007
- Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2005
- Separation methods for acyclovir and related antiviral compoundsJournal of Chromatography B: Biomedical Sciences and Applications, 2001